Læknablaðið - 15.07.2006, Qupperneq 16

FRÆÐIGREINAR / SKIMUN í RISTLI OG ENDAÞARMI
7. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM,
Amar SS, Balfour TW, et al. Randomised controlled trial of
faecal-occult-blood screening for colorectal cancer. Lancet
1996;348:1472-7.
8. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard
O. Randomised study of screening for colorectal cancer with
faecal-occult-blood test. Lancet 1996; 348:1467-71.
9. UK Flexible Sigmoidoscopy Screening Trial Investigators.
Single flexible sigmoidoscopy screening to prevent colorectal
cancer: baseline findings of a UK multicentre randomised trial.
Lancet 2002; 359:1291-300.
10. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C,
et al. Baseline findings of the Italian multicenter randomized
controlled trial of „once-only sigmoidoscopy“. SCORE. N
Natl Cancer Inst 2002; 94:1763-72.
11. Palitz AM, Selby JV, Grossman S, Finkler LJ, Bevc M, Kehr C,
et al. The Colon Cancer Prevention Program (CoCaP): ratio-
nale, implementation, and preliminary results. HMO Practice
1997;11:5-12.
12. WHO National Cancer Control Programmes. Policies and
managerial guidelines. 2nd edition. Geneva 2002.
13. Nekhlyudov L, Li R, Fletcher SW. Information and involve-
ment preferences of women in their 40s before their first
screening mammogram. Arch Intern Med 2005; 165:1370-4.
14. Hoff G, Bretthauer M.The science and politics of colorectal
cancer screening. PloS Medicine 2006; 3: e36.
15. www.ancr.nu/nordcan.asp (14.03.06)
Birting íslenskrar fræðigreina í erlendu tímariti
Georgsson G,Tryggvason T, Jónasdóttir AD, Guðmundsson S, Þorgeirsdóttir S
Polymorphisni of PRNP codons in the norma) Icelandic population
Acta Neurologica Scandinavica 2006; 113:419-25
524 Læknablaðið 2006/92